Willingness To Pay To Eliminate the Risk of Restenosis Following Percutaneous Coronary Intervention A Contingent Valuation

被引:2
|
作者
Guertin, Jason R. [1 ,2 ]
Liu, Aihua [3 ,4 ]
Abrahamowicz, Michal [3 ,4 ]
Cohen, David J. [6 ]
Ismail, Salma [2 ]
LeLorier, Jacques [1 ,2 ]
Brophy, James M. [3 ,4 ,5 ]
Rinfret, Stephane [2 ,7 ]
机构
[1] Univ Montreal, Montreal, PQ H3C 3J7, Canada
[2] Ctr Hosp Univ Montreal, Res Ctr, Montreal, PQ, Canada
[3] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada
[5] McGill Univ, Ctr Hlth, Div Cardiol, Montreal, PQ, Canada
[6] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[7] Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada
来源
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2011年 / 4卷 / 01期
关键词
restenosis; stents; cost-benefit analysis; SIROLIMUS-ELUTING STENTS; HIERARCHICAL BAYESIAN METAANALYSIS; HEALTH-CARE; COST-EFFECTIVENESS; ECONOMIC-EVALUATION; ANGIOPLASTY; TRIALS;
D O I
10.1161/CIRCOUTCOMES.109.915421
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Percutaneous coronary intervention (PCI) remains limited by the risk of restenosis. Patients' perceptions of the health benefits and value of avoiding restenosis are incompletely known. Methods and Results-We used a contingent valuation approach to assess the willingness to pay (WTP) for a hypothetical treatment that eliminates the risk of restenosis among 270 PCI patients. Patients were provided with a scenario describing a baseline 10% or 20% probability of restenosis in the year following the procedure, which could lead to repeat PCI or, more rarely, bypass surgery, without any increase in mortality. Six different "take it or leave it" bids ($500, $1000, $1500, $2000, $2500, and $3000) and both risk levels were randomly assigned. Multiple logistic regression was used to identify independent predictors of a positive response to the WTP question. Using nonparametric methods, the median WTP to eliminate the risk of restenosis was estimated at $2802. As expected, higher income was independently associated with a higher probability of a positive response to the WTP question (odds ratio, 2.81; 95% CI, 1.32 to 5.97). Bids also were independently associated with the probability of being willing to pay, and this association followed a quadratic effect. Below $1500, bid had little impact on patient answers. However, as prices increased, the probability of being willing to pay started to decrease sharply. Conclusion-The potential to eliminate the risk of restenosis, a benign complication, would have substantial value for patients undergoing PCI. (Circ Cardiovasc Qual Outcomes. 2011;4:46-52.)
引用
收藏
页码:46 / 52
页数:7
相关论文
共 50 条
  • [21] Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery
    Spertus, JA
    Nerella, R
    Kettlekamp, R
    House, J
    Marso, S
    Borkon, AM
    Rumsfeld, JS
    CIRCULATION, 2005, 111 (06) : 768 - 773
  • [22] Hypothetical assessment of efficiency, willingness-to-accept and willingness-to-pay for dengue vaccine and treatment: a contingent valuation survey in Bangladesh
    Kabir, K. M. Ariful
    Hagishima, Aya
    Tanimoto, Jun
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 773 - 784
  • [23] Eliciting willingness-to-pay to prevent hospital medication administration errors in the UK: a contingent valuation survey
    Hill, Sarah R.
    Bhattarai, Nawaraj
    Tolley, Clare L.
    Slight, Sarah P.
    Vale, Luke
    BMJ OPEN, 2022, 12 (02):
  • [24] Willingness to pay for what? A note on alternative definitions of health care program benefits for contingent valuation studies
    Currie, GR
    Donaldson, C
    O'Brien, BJ
    Stoddart, GL
    Torrance, GW
    Drummond, MF
    MEDICAL DECISION MAKING, 2002, 22 (06) : 493 - 497
  • [25] THE PARADIGM OF RESTENOSIS FOLLOWING PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY
    PREISACK, MB
    KARSCH, KR
    EUROPEAN HEART JOURNAL, 1993, 14 : 187 - 192
  • [26] Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention - Another smoker's paradox?
    Cohen, DJ
    Doucet, M
    Cutlip, DE
    Ho, KKL
    Popma, JJ
    Kuntz, RE
    CIRCULATION, 2001, 104 (07) : 773 - 778
  • [27] Predicting the Restenosis Benefit of Drug-Eluting Versus Bare Metal Stents in Percutaneous Coronary Intervention
    Yeh, Robert W.
    Normand, Sharon-Lise T.
    Wolf, Robert E.
    Jones, Philip G.
    Ho, Kalon K. L.
    Cohen, David J.
    Cutlip, Donald E.
    Mauri, Laura
    Kugelmass, Aaron D.
    Amin, Amit P.
    Spertus, John A.
    CIRCULATION, 2011, 124 (14) : 1557 - +
  • [28] Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention
    Kullmann, Silke
    Binner, Priska
    Rackebrandt, Kirsten
    Huge, Andreas
    Haltern, Georg
    Lankisch, Mark
    Fueth, Reiner
    von Hodenberg, Eberhard
    Bestehorn, Hans-Peter
    Scheffold, Thomas
    BMC CARDIOVASCULAR DISORDERS, 2009, 9 : 48
  • [29] Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis?
    Pepe, Martino
    Napoli, Gianluigi
    Carulli, Eugenio
    Moscarelli, Marco
    Forleo, Cinzia
    Nestola, Palma Luisa
    Biondi-Zoccai, Giuseppe
    Giordano, Arturo
    Favale, Stefano
    ATHEROSCLEROSIS, 2021, 333 : 24 - 31
  • [30] Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä, A
    Hartikainen, J
    ANNALS OF MEDICINE, 2006, 38 (03) : 173 - 187